Trial intelligence / Profile preview

Clinical validation of factor VIII allo-antibody assays in severe hemophilia A

NL-OMON31749Recruiting

Sponsor
Radboud University Medical Center
Start
Dec 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of Factor VIII in hemophilia A (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Correlation between antibody assays and factor VIII pharmacokinetics and Diagnostic performance of antibody assays. Started Dec 2008; status: recruiting.

02

Drugs

Factor VIII
03

Conditions

hemophilia A

Beyond the preview

Go deeper on NL-OMON31749.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31749.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call